HSBC Holdings’s Tiziana Life Sciences TLSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$75.5K Hold
62,437
﹤0.01% 2776
2025
Q4
$94.3K Sell
62,437
-12,928
-17% -$23.2K ﹤0.01% 2798
2025
Q3
$160K Sell
75,365
-30,000
-28% -$55.5K ﹤0.01% 2530
2025
Q2
$166K Hold
105,365
﹤0.01% 2734
2025
Q1
$114K Hold
105,365
﹤0.01% 2781
2024
Q4
$73.8K Sell
105,365
-10,000
-9% -$9.25K ﹤0.01% 2939
2024
Q3
$113K Sell
115,365
-10,000
-8% -$10.1K ﹤0.01% 2776
2024
Q2
$118K Sell
125,365
-38,861
-24% -$28.4K ﹤0.01% 2700
2024
Q1
$70.8K Hold
164,226
﹤0.01% 2897
2023
Q4
$92.1K Sell
164,226
-20,000
-11% -$12.6K ﹤0.01% 2607
2023
Q3
$123K Sell
184,226
-121,041
-40% -$83.3K ﹤0.01% 2524
2023
Q2
$212K Hold
305,267
﹤0.01% 2298
2023
Q1
$305K Hold
305,267
﹤0.01% 2228
2022
Q4
$183K Hold
305,267
﹤0.01% 2792
2022
Q3
$234K Hold
305,267
﹤0.01% 2545
2022
Q2
$227K Sell
305,267
-140,287
-31% -$121K ﹤0.01% 2816
2022
Q1
$468K Sell
445,554
-60,000
-12% -$53.1K ﹤0.01% 2461
2021
Q4
$536K Buy
+505,554
New +$670K ﹤0.01% 2423

Other funds holding TLSA

HSBC Holdings's TLSA Position: Q1 2026 in Review

HSBC Holdings held its Tiziana Life Sciences (TLSA) position steady in Q1 2026 at 62,437 shares worth $75.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2776.

HSBC Holdings first reported a position in TLSA in Q4 2021 and has held it in 18 quarters since. The position peaked at $536K in Q4 2021. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2026.

  • HSBC Holdings held 62,437 shares of Tiziana Life Sciences worth $75.5K as of Q1 2026.
  • HSBC Holdings left its Tiziana Life Sciences share count unchanged in Q1 2026.
  • Tiziana Life Sciences made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2776 holding.
  • HSBC Holdings first reported a position in Tiziana Life Sciences in Q4 2021 and has held it in 18 quarters since.
  • HSBC Holdings's Tiziana Life Sciences position peaked at $536K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.